• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后脊柱和长骨骨折的流行病学。绝经后骨质疏松症的统一研究方法。

Epidemiology of postmenopausal spinal and long bone fractures. A unifying approach to postmenopausal osteoporosis.

作者信息

Jensen G F, Christiansen C, Boesen J, Hegedüs V, Transbøl I

出版信息

Clin Orthop Relat Res. 1982 Jun(166):75-81.

PMID:7083689
Abstract

The incidence of spontaneous postmenopausal fractures and their relationship to menopausal age and bone mass were determined in a representative sample of 70-year-old Danish women. Two hundred and eighty-five women (1.2% of all women in that age group) were examined by case history, by 125I photon absorptiometry in both forearms (BMC), by metacarpal index (CA/TA), and by lateral radiographs of the spine. Twenty-four per cent of the participants had sustained single fractures, and 20% multiple fractures. Nineteen per cent had fractures of the lower forearm, 5% of the proximal humerus, 4% of the hip, and 5% crush fractures of the spine. These comprise Group I fractures, the most definite expressions of osteoporosis. The remaining other long bone fractures (7%) and spinal wedge fractures (18%) comprise Group II fractures. Group I cases were characterized by an earlier onset of the menopause and a definite decrease in bone mass, as judged from BMC and CA/TA, as compared with the nonfracture group. Group II cases did not display this distinction. Of Group I cases, those with multifractures differed from those with single fractures by having a five-year earlier occurrence of first fracture, a further decrease in bone mass, and a slightly raised serum alkaline phosphatase level. Serum calcium and phosphate levels were the same in all groups.

摘要

在一组具有代表性的70岁丹麦女性样本中,确定了绝经后自发性骨折的发生率及其与绝经年龄和骨量的关系。通过病史、双侧前臂的125I光子吸收法(骨矿物质含量)、掌骨指数(CA/TA)以及脊柱侧位X线片对285名女性(该年龄组所有女性的1.2%)进行了检查。24%的参与者发生过单发骨折,20%发生过多发骨折。19%发生过前臂远端骨折,5%发生过肱骨近端骨折,4%发生过髋部骨折,5%发生过脊柱压缩性骨折。这些构成了I组骨折,是骨质疏松最明确的表现。其余的其他长骨骨折(7%)和脊柱楔形骨折(18%)构成II组骨折。与未骨折组相比,I组病例的特点是绝经 onset较早,从骨矿物质含量和掌骨指数判断骨量明显减少。II组病例没有表现出这种差异。在I组病例中,多发骨折者与单发骨折者的不同之处在于首次骨折发生时间早五年、骨量进一步减少以及血清碱性磷酸酶水平略有升高。所有组的血清钙和磷水平相同。

相似文献

1
Epidemiology of postmenopausal spinal and long bone fractures. A unifying approach to postmenopausal osteoporosis.绝经后脊柱和长骨骨折的流行病学。绝经后骨质疏松症的统一研究方法。
Clin Orthop Relat Res. 1982 Jun(166):75-81.
2
Detection of prefracture spinal osteoporosis using bone mineral absorptiometry.使用骨矿物质吸收测定法检测骨折前脊柱骨质疏松症。
J Bone Miner Res. 1988 Feb;3(1):1-11. doi: 10.1002/jbmr.5650030103.
3
Association between low lean body mass and osteoporotic fractures after menopause.绝经后低瘦体重与骨质疏松性骨折之间的关联。
Menopause. 2008 Sep-Oct;15(5):905-13. doi: 10.1097/gme.0b013e318164ee85.
4
[Screening for postmenopausal osteoporosis. Women with distal radius fractures should be evaluated for bone density].[绝经后骨质疏松症的筛查。桡骨远端骨折的女性应评估骨密度]
Lakartidningen. 2003 Jan 9;100(1-2):31-4.
5
[Epidemiology of osteoporosis].[骨质疏松症的流行病学]
Schweiz Med Wochenschr. 1997 Apr 19;127(16):659-67.
6
Relationship between bone mineral content and frequency of postmenopausal fractures.骨矿物质含量与绝经后骨折发生率之间的关系。
Acta Med Scand. 1983;213(1):61-3. doi: 10.1111/j.0954-6820.1983.tb03691.x.
7
Fracture frequency and bone preservation in postmenopausal women treated with estrogen.接受雌激素治疗的绝经后女性的骨折发生率及骨质保存情况。
Obstet Gynecol. 1982 Oct;60(4):493-6.
8
Endogenous cortisol and sex steroids in patients with osteoporotic spinal fractures.骨质疏松性脊柱骨折患者的内源性皮质醇和性激素
Obstet Gynecol. 1983 Mar;61(3):275-8.
9
Lactose intolerance: a risk factor for reduced bone mineral density and vertebral fractures?乳糖不耐受:骨密度降低和椎体骨折的一个风险因素?
J Gastroenterol. 2002;37(12):1014-9. doi: 10.1007/s005350200171.
10
Relative contributions of aging and estrogen deficiency to postmenopausal bone loss.衰老和雌激素缺乏对绝经后骨质流失的相对影响。
N Engl J Med. 1984 Nov 15;311(20):1273-5. doi: 10.1056/NEJM198411153112002.

引用本文的文献

1
Osteoporosis among Fallers without Concomitant Fracture Identified in an Emergency Department: Frequencies and Risk Factors.急诊科中未伴有骨折的跌倒者的骨质疏松症:发生率及危险因素
Adv Orthop. 2011;2011:468717. doi: 10.4061/2011/468717. Epub 2010 Nov 8.
2
The prevalence of vertebral fractures and health-related quality of life in postmenopausal women.绝经后妇女的椎体骨折患病率和健康相关生活质量。
Rheumatol Int. 2012 Apr;32(4):971-80. doi: 10.1007/s00296-010-1734-5. Epub 2011 Jan 18.
3
Clinical risk factor assessment had better discriminative ability than bone mineral density in identifying subjects with vertebral fracture.
临床风险因素评估比骨密度更能准确识别椎体骨折患者。
Osteoporos Int. 2011 Feb;22(2):667-74. doi: 10.1007/s00198-010-1260-z. Epub 2010 May 26.
4
Gender differences in trabecular bone architecture of the distal radius assessed with magnetic resonance imaging and implications for mechanical competence.利用磁共振成像评估桡骨远端小梁骨结构的性别差异及其对力学性能的影响。
Osteoporos Int. 2005 Sep;16(9):1124-33. doi: 10.1007/s00198-004-1823-y. Epub 2005 Mar 3.
5
Physiologic effects of steroid hormones and postmenopausal hormone replacement on the female breast and breast cancer risk.类固醇激素及绝经后激素替代疗法对女性乳房的生理影响及乳腺癌风险
Ann Surg. 1998 Nov;228(5):638-51. doi: 10.1097/00000658-199811000-00003.
6
A risk-benefit assessment of alendronate in the treatment of involutional osteoporosis.阿仑膦酸钠治疗绝经后骨质疏松症的风险效益评估。
Drug Saf. 1998 Aug;19(2):141-54. doi: 10.2165/00002018-199819020-00005.
7
Diagnosis of osteoporosis.骨质疏松症的诊断。
Osteoporos Int. 1997;7 Suppl 3:S108-16. doi: 10.1007/BF03194355.
8
The technical and logistical feasibility of population densitometry using DXA and directed HRT intervention: a 2-year prospective study.使用双能X线吸收仪进行人群密度测定及定向激素替代疗法干预的技术与后勤可行性:一项为期2年的前瞻性研究。
Osteoporos Int. 1996;6 Suppl 3:31-6. doi: 10.1007/BF01623762.
9
Fluoride therapy of type I osteoporosis.I型骨质疏松症的氟化物治疗。
Clin Rheumatol. 1995 Sep;14 Suppl 3:26-31. doi: 10.1007/BF02210685.
10
Hormone replacement therapy in the aged. A state of the art review.
Drugs Aging. 1996 Mar;8(3):193-213. doi: 10.2165/00002512-199608030-00005.